Time since End of Radiotherapy Treatment | ||||||
---|---|---|---|---|---|---|
Characteristic | Total (n = 44) | Cohort 1 ≤2.5 years (n = 11) | Cohort 2 >2.5–6 years (n = 13) | Cohort 3 >6–10 years (n = 9) | Cohort 4 >10 years (n = 11) | p-value |
Mean time since end of RT (months) | 74.6 | 15.6 | 49.0 | 93.6 | 144.3 | |
Range of time since end of RT (months) | 5–162 | 5–28 | 31–68 | 69–116 | 128–162 | |
Age at time of treatment: mean ± SD (years) | 49.2 ± 13.9 | 53.2 ± 9.5 | 52.8 ± 13.8 | 41.3 ± 14.6 | 48.6 ± 15.6 | |
Age at time of survey: mean ± SD (years) | 55.5 ± 13.8 | 54.5 ± 9.7 | 57.3 ± 13.9 | 47.7 ± 14.7 | 60.6 ± 15.4 | 0.20 |
Gender | 0.88 | |||||
Men | 35 | 9 | 10 | 8 | 8 | |
Women | 9 | 2 | 3 | 1 | 3 | |
Ethnicity | 0.13 | |||||
Asian Pacific Islander (API) | 34 | 11 | 8 | 7 | 8 | |
Non-API | 10 | 0 | 5 | 2 | 3 | |
Language | 0.005 | |||||
English | 31 | 3 | 10 | 8 | 10 | |
Non-English | 13 | 8 | 3 | 1 | 1 | |
AJCC Stage (6th Ed.) | 0.78 | |||||
I or II | 13 | 3 | 5 | 3 | 2 | |
III or IV | 31 | 8 | 8 | 6 | 9 | |
Radiation Type | 0.15 | |||||
Forward-planned IMRT | 2 | 0 | 0 | 0 | 2 | |
Inverse-planned IMRT | 42 | 11 | 13 | 9 | 9 | |
Chemotherapy | 0.04 | |||||
None | 6 | 1 | 4 | 0 | 1 | |
Concurrent Only | 8 | 1 | 2 | 0 | 5 | |
Concurrent + Adjuvant | 30 | 9 | 7 | 9 | 5 |